KROS Insider Transactions — Page 6
533 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 501–533; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Pontifax (China) IV L.P. | TenPercentOwner | 2020-04-13 | Purchase | 105,000.0 | $16.0 |
| Pontifax (Israel) IV, L.P. | TenPercentOwner | 2020-04-13 | Purchase | 105,000.0 | $16.0 |
| Pontifax Management 4 G.P. (2015) Ltd. | TenPercentOwner | 2020-04-13 | Purchase | 105,000.0 | $16.0 |
| Pontifax Late Stage Fund L.P. | TenPercentOwner | 2020-04-13 | Purchase | 105,000.0 | $16.0 |
| Pontifax Late Stage GP Ltd. | TenPercentOwner | 2020-04-13 | Purchase | 105,000.0 | $16.0 |
| Pontifax (Cayman) IV L.P. | TenPercentOwner | 2020-04-13 | Purchase | 94,546.0 | $16.0 |
| Pontifax (China) IV L.P. | TenPercentOwner | 2020-04-13 | Purchase | 94,546.0 | $16.0 |
| Pontifax (Israel) IV, L.P. | TenPercentOwner | 2020-04-13 | Purchase | 94,546.0 | $16.0 |
| Pontifax Management 4 G.P. (2015) Ltd. | TenPercentOwner | 2020-04-13 | Purchase | 94,546.0 | $16.0 |
| Pontifax Late Stage Fund L.P. | TenPercentOwner | 2020-04-13 | Purchase | 94,546.0 | $16.0 |
| Pontifax Late Stage GP Ltd. | TenPercentOwner | 2020-04-13 | Purchase | 94,546.0 | $16.0 |
| Pontifax (Cayman) IV L.P. | TenPercentOwner | 2020-04-13 | Purchase | 194,203.0 | $16.0 |
| Pontifax (China) IV L.P. | TenPercentOwner | 2020-04-13 | Purchase | 194,203.0 | $16.0 |
| Pontifax (Israel) IV, L.P. | TenPercentOwner | 2020-04-13 | Purchase | 194,203.0 | $16.0 |
| Pontifax Management 4 G.P. (2015) Ltd. | TenPercentOwner | 2020-04-13 | Purchase | 194,203.0 | $16.0 |
| Pontifax Late Stage Fund L.P. | TenPercentOwner | 2020-04-13 | Purchase | 194,203.0 | $16.0 |
| Pontifax Late Stage GP Ltd. | TenPercentOwner | 2020-04-13 | Purchase | 194,203.0 | $16.0 |
| ORBIMED ADVISORS LLC | Director | 2020-04-13 | Purchase | 375,200.0 | $16.0 |
| OrbiMed Capital GP VII LLC | Director | 2020-04-13 | Purchase | 375,200.0 | $16.0 |
| OrbiMed Genesis GP LLC | Director | 2020-04-13 | Purchase | 375,200.0 | $16.0 |
| Nussbaum Ran | Director,TenPercentOwner | 2020-04-13 | Purchase | 43,750.0 | $16.0 |
| Nussbaum Ran | Director,TenPercentOwner | 2020-04-13 | Purchase | 105,000.0 | $16.0 |
| Nussbaum Ran | Director,TenPercentOwner | 2020-04-13 | Purchase | 94,546.0 | $16.0 |
| Nussbaum Ran | Director,TenPercentOwner | 2020-04-13 | Purchase | 194,203.0 | $16.0 |
| Lazarus Alon | Director,TenPercentOwner | 2020-04-13 | Purchase | 120,000.0 | $16.0 |
| Kariv Tomer | Director,TenPercentOwner | 2020-04-13 | Purchase | 43,750.0 | $16.0 |
| Kariv Tomer | Director,TenPercentOwner | 2020-04-13 | Purchase | 105,000.0 | $16.0 |
| Kariv Tomer | Director,TenPercentOwner | 2020-04-13 | Purchase | 94,546.0 | $16.0 |
| Kariv Tomer | Director,TenPercentOwner | 2020-04-13 | Purchase | 194,203.0 | $16.0 |
| GORDON CARL L | Director | 2020-04-13 | Purchase | 375,200.0 | $16.0 |
| Arkin Moshe | TenPercentOwner | 2020-04-13 | Purchase | 120,000.0 | $16.0 |
| Arkin Bio Ventures Limited Partnership | TenPercentOwner | 2020-04-13 | Purchase | 120,000.0 | $16.0 |
| Arkin Bio Venture Partners Ltd. | TenPercentOwner | 2020-04-13 | Purchase | 120,000.0 | $16.0 |